Perspective Therapeutics Files 8-K
Ticker: CATX · Form: 8-K · Filed: Feb 3, 2025 · CIK: 728387
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Perspective Therapeutics (formerly Isoray) filed an 8-K on Feb 3, 2025. Standard reporting.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on February 3, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This filing provides an update on the company's corporate events and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, indicating no immediate significant events or changes.
Key Numbers
- 001-33407 — SEC File Number (Identifies the company's filing with the SEC)
- 41-1458152 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- Isoray, Inc. (company) — Former company name
- February 03, 2025 (date) — Date of earliest event reported
- Seattle, Washington (location) — Company headquarters
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of February 3, 2025.
What was Perspective Therapeutics, Inc. formerly known as?
Perspective Therapeutics, Inc. was formerly known as Isoray, Inc. and IsoRay, Inc.
In which state is Perspective Therapeutics, Inc. incorporated?
Perspective Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Perspective Therapeutics, Inc.?
The business address is 2401 Elliott Avenue, Suite 320, Seattle, Washington, 98121.
What is the SIC code for Perspective Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2025-02-03 16:09:30
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CATX NYSE American LLC
Filing Documents
- catx-20250203.htm (8-K) — 42KB
- catx-ex99_1.htm (EX-99.1) — 60KB
- catx-ex99_1s1.jpg (GRAPHIC) — 148KB
- catx-ex99_1s2.jpg (GRAPHIC) — 694KB
- catx-ex99_1s3.jpg (GRAPHIC) — 330KB
- catx-ex99_1s4.jpg (GRAPHIC) — 308KB
- catx-ex99_1s5.jpg (GRAPHIC) — 339KB
- catx-ex99_1s6.jpg (GRAPHIC) — 284KB
- catx-ex99_1s7.jpg (GRAPHIC) — 116KB
- catx-ex99_1s8.jpg (GRAPHIC) — 307KB
- catx-ex99_1s9.jpg (GRAPHIC) — 425KB
- catx-ex99_1s10.jpg (GRAPHIC) — 429KB
- catx-ex99_1s11.jpg (GRAPHIC) — 328KB
- catx-ex99_1s12.jpg (GRAPHIC) — 292KB
- catx-ex99_1s13.jpg (GRAPHIC) — 365KB
- catx-ex99_1s14.jpg (GRAPHIC) — 345KB
- catx-ex99_1s15.jpg (GRAPHIC) — 147KB
- catx-ex99_1s16.jpg (GRAPHIC) — 279KB
- catx-ex99_1s17.jpg (GRAPHIC) — 484KB
- catx-ex99_1s18.jpg (GRAPHIC) — 133KB
- catx-ex99_1s19.jpg (GRAPHIC) — 370KB
- catx-ex99_1s20.jpg (GRAPHIC) — 386KB
- catx-ex99_1s21.jpg (GRAPHIC) — 241KB
- catx-ex99_1s22.jpg (GRAPHIC) — 393KB
- catx-ex99_1s23.jpg (GRAPHIC) — 231KB
- catx-ex99_1s24.jpg (GRAPHIC) — 312KB
- catx-ex99_1s25.jpg (GRAPHIC) — 412KB
- catx-ex99_1s26.jpg (GRAPHIC) — 190KB
- catx-ex99_1s27.jpg (GRAPHIC) — 357KB
- catx-ex99_1s28.jpg (GRAPHIC) — 370KB
- catx-ex99_1s29.jpg (GRAPHIC) — 133KB
- catx-ex99_1s30.jpg (GRAPHIC) — 326KB
- catx-ex99_1s31.jpg (GRAPHIC) — 396KB
- catx-ex99_1s32.jpg (GRAPHIC) — 391KB
- catx-ex99_1s33.jpg (GRAPHIC) — 259KB
- catx-ex99_1s34.jpg (GRAPHIC) — 381KB
- catx-ex99_1s35.jpg (GRAPHIC) — 284KB
- catx-ex99_1s36.jpg (GRAPHIC) — 439KB
- catx-ex99_1s37.jpg (GRAPHIC) — 345KB
- catx-ex99_1s38.jpg (GRAPHIC) — 152KB
- catx-ex99_1s39.jpg (GRAPHIC) — 342KB
- catx-ex99_1s40.jpg (GRAPHIC) — 379KB
- catx-ex99_1s41.jpg (GRAPHIC) — 339KB
- catx-ex99_1s42.jpg (GRAPHIC) — 268KB
- catx-ex99_1s43.jpg (GRAPHIC) — 253KB
- catx-ex99_1s44.jpg (GRAPHIC) — 257KB
- catx-ex99_1s45.jpg (GRAPHIC) — 333KB
- catx-ex99_1s46.jpg (GRAPHIC) — 98KB
- catx-ex99_1s47.jpg (GRAPHIC) — 332KB
- catx-ex99_1s48.jpg (GRAPHIC) — 295KB
- catx-ex99_1s49.jpg (GRAPHIC) — 297KB
- catx-ex99_1s50.jpg (GRAPHIC) — 278KB
- 0000950170-25-012317.txt ( ) — 21709KB
- catx-20250203.xsd (EX-101.SCH) — 25KB
- catx-20250203_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On February 3, 2025, Perspective Therapeutics, Inc. posted an updated corporate presentation on its website at www.perspectivetherapeutics.com. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: February 3, 2025 By: /s/ Johan (Thijs) Spoor Johan (Thijs) Spoor, Chief Executive Officer